Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Jeffrey G Weers
Introduction
Jeffrey G Weers is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pulmonary delivery systems. His work focuses on developing medicaments that enhance the delivery of active agents to the lungs.
Latest Patents
Jeffrey G Weers holds a patent for "Pulmonary delivery particles comprising an active agent." This patent describes a pulmonary delivery medicament that consists of a plurality of particulates. The particulates are composed of a structural matrix and a water-insoluble and/or crystalline active agent. The geometric diameter of these particulates ranges from 0.5 to 50 µm. The water-insoluble active agent can include a fungicide, antibiotic, or budesonide. The method of creating this medicament involves forming a liquid feedstock and a feedstock suspension by suspending the active agent and an excipient capable of forming a structural matrix, such as a phospholipid. The feedstock suspension is then spray-dried to produce the particulates.
Career Highlights
Jeffrey G Weers is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis focuses on innovative solutions in the pharmaceutical industry. He has demonstrated a commitment to advancing medical technology through his research and development efforts.
Collaborations
Some of his notable coworkers include Thomas E Tarara and Alexey S Kabalnov. Their collaboration has contributed to the success of various projects within the company.
Conclusion
Jeffrey G Weers is a prominent inventor whose work in pulmonary delivery systems has the potential to significantly impact healthcare. His innovative approach to medicament development showcases the importance of research in improving patient outcomes.